2.8. Subgroup Analysis
We also conducted a set of subgroup analyses in the current study. When only analyzing women, ΔI-FABP (W8-W0) was negative, indicating a reduction over the study period within the treatment group (−22.04 ± −379.00 pg/mL), while with the females in the placebo group, the delta was positive (61.89 ± −217.58 pg/mL); rendering the ΔI-FABP significantly lower in the treatment group as compared to the placebo group (